Breast cancer patients who take aspirin regularly after undergoing treatment may be less likely to die or be struck down with cancer for a second time, according to new research. “The study of more than 4,000 nurses showed that those who took aspirin — usually to prevent heart disease — had a 50 percent lower risk of dying from breast cancer and a 50 percent lower risk that the cancer would spread. ‘This is the first study to find that aspirin can significantly reduce the risk of cancer spread and death for women who have been treated for early stage breast cancer,’ said Dr. Michelle Holmes of Harvard Medical School, who led the study published in the Journal of Clinical Oncology. ‘If these findings are confirmed in other clinical trials, taking aspirin may become another simple, low-cost and relatively safe tool to help women with breast cancer live longer, healthier lives,’ Holmes added in a statement. Holmes and her team studied 4,164 female registered nurses taking part in the Nurses’ Health Study, an ongoing analysis of a wide range of health issues. They started in 1976, looking at who took aspirin, watching for breast cancer and all causes of death until 2006. Over this time, 341 of the nurses died of breast cancer. Women who took aspirin two to five days a week had a 60 percent reduced risk of their cancer spreading and a 71 percent lower risk of breast cancer death.”
You know ChatGPT, but how much do you know about the company that made it? Journalist Karen Hao joins us to talk OpenAI’s latest implosion.
There are steps we can take to create a new paradigm that will help shift society's attitude towards women in the workplace.
Lockdowns moved the burden of COVID from the at-risk elderly to the less-at-risk young. Does this sacrifice merit compensation?
How much do citizens really value free elections?
Fraud is a $5 trillion “industry.” But not all its perpetrators look alike. Kelly Richmond Pope, a professor of accounting, breaks down who commits fraud — and why.